Back
Science

Ohio State Study Objectively Measures Multisensory Losses in Long COVID Patients

Generated on: Last updated: 1 sources
View source

Understanding Multisensory Loss in Long COVID: A New Objective Study

The Ohio State University College of Medicine has conducted the first objective study to measure multisensory losses in long COVID patients. This groundbreaking research indicates that the severity and scope of sensory dysfunctions are significantly influenced by patient age, the initial severity of COVID-19, and cognitive functions. The study aims to improve care for long COVID patients by providing a deeper understanding of the variations in sensory loss profiles.

This marks the first objective study to measure multisensory losses in long COVID patients, highlighting the influence of age, initial disease severity, and cognitive function on sensory dysfunctions.

Study Design and Participants

Published in BMC Medicine, the study included 60 patients aged 27 to 78 who contracted COVID-19 between January 1, 2020, and December 21, 2023. All participants experienced persistent symptoms for four to 50 months. Each patient had self-reported complaints in at least one of the following areas: smell, taste, balance/dizziness, hearing, or brain fog.

Standardized objective assessments were meticulously performed to evaluate:

  • Smell
  • Taste
  • Hearing
  • Vestibular function
  • Balance/dizziness
  • Cognitive function

Most participants had mild initial COVID-19 cases, with only eight requiring hospitalization; two of these needed breathing tubes. The study rigorously excluded patients with pre-existing conditions that could confound results, such as prior smell, taste, hearing, or balance issues, neurological conditions, severe health problems unrelated to COVID-19, a history of severe head trauma, or pregnancy.

Key Findings and Associations

Patients reported a high incidence of overlapping issues, revealing the widespread nature of long COVID symptoms:

  • Smell: 67.3%
  • Taste: 63.6%
  • Balance and Dizziness: 56.6%
  • Hearing: 31.8%
  • Brain Fog/Cognitive Issues: 51.3%

Objective assessments provided crucial confirmation of these dysfunctions, though often at different rates:

  • Smell: 65.5%
  • Taste: 16%
  • Balance and Dizziness: 31.6%
  • Hearing: 53.4%
  • Brain Fog/Cognitive Issues: 19.1%

The research identified several strong associations, pointing to underlying biological mechanisms:

  • Strong associations were found between confirmed balance/dizziness and hearing impairments, potentially due to the shared inner ear structure of the auditory and vestibular systems.
  • Associations were also observed among brain fog, balance, and hearing impairments, suggesting central nervous system involvement.
  • Furthermore, strong associations were seen between patients with smell and taste issues, particularly in tasks requiring cognitive involvement, such as recognizing flavors or odors.

The impact of initial disease severity was clearly highlighted: All eight hospitalized patients exhibited confirmed smell dysfunction, seven had confirmed balance dysfunction, six had hearing loss, and four had cognitive dysfunction.

Future Research Directions

Future studies are planned to longitudinally track these long COVID patients, both objectively and subjectively. This will help to understand how symptoms may improve over time and to provide more accurate prognosis predictions.

The ultimate goal is to further investigate the systematic impact of long COVID and to explain the wide variation in sensory and cognitive symptoms, aiming to significantly improve patient care for those living with long COVID.